TY - JOUR
T1 - Exercise oscillatory ventilation
T2 - Interreviewer agreement and a novel determination
AU - Brawner, Clinton A.
AU - Ehrman, Jonathan K.
AU - Myers, Jonathan
AU - Chase, Paul
AU - Vainshelboim, Baruch
AU - Farha, Shadi
AU - Saval, Matthew A.
AU - McGuire, Rita
AU - Pozehl, Bunny
AU - Keteyian, Steven J.
N1 - Funding Information:
The HEART Camp study (clinicaltrials.gov NCT01658670) was supported by a grant from the National, Heart, Blood, and Lung Institute of the National Institutes of Health (award R01HL112979). This agency
Publisher Copyright:
© 2018 Lippincott Williams and Wilkins. All rights reserved.
PY - 2018
Y1 - 2018
N2 - Introduction: Determination of exercise oscillatory ventilation (EOV) is subjective, and the interreviewer agreement has not been reported. The purposes of this study were, among patients with heart failure (HF), as follows: 1) to determine the interreviewer agreement for EOV and 2) to describe a novel, objective, and quantifiable measure of EOV. Methods: This was a secondary analysis of the HEART Camp: Promoting Adherence to Exercise in Patients with Heart Failure study. EOV was determined through a blinded review by six individuals on the basis of their interpretation of the EOV literature. Interreviewer agreement was assessed using Fleiss kappa (J). Final determination of EOV was based on agreement by four of the six reviewers. A new measure (ventilation dispersion index; VDI) was calculated for each test, and its ability to predict EOV was assessed with the receiver operator characteristics curve. Results: Among 243 patients with HF (age, 60 T 12 yr; 45% women), the interreviewer agreement for EOV was fair (J = 0.303) with 10-s discrete data averages and significantly better, but only moderate (J = 0.429) with 30-s rolling data averages. Prevalence rates of positive and indeterminate EOVs were 18% and 30% with the 10-s discrete averages and 14% and 13% with the 30-s rolling averages, respectively. VDI was strongly associated with EOV, with areas under the receiver operator characteristics curve of 0.852 to 0.890. Conclusions: Interreviewer agreement for EOV in patients with HF is fair to moderate, which can negatively affect risk stratification. VDI has strong predictive validity with EOV; as such, it might be a useful measure of prognosis in patients with HF.
AB - Introduction: Determination of exercise oscillatory ventilation (EOV) is subjective, and the interreviewer agreement has not been reported. The purposes of this study were, among patients with heart failure (HF), as follows: 1) to determine the interreviewer agreement for EOV and 2) to describe a novel, objective, and quantifiable measure of EOV. Methods: This was a secondary analysis of the HEART Camp: Promoting Adherence to Exercise in Patients with Heart Failure study. EOV was determined through a blinded review by six individuals on the basis of their interpretation of the EOV literature. Interreviewer agreement was assessed using Fleiss kappa (J). Final determination of EOV was based on agreement by four of the six reviewers. A new measure (ventilation dispersion index; VDI) was calculated for each test, and its ability to predict EOV was assessed with the receiver operator characteristics curve. Results: Among 243 patients with HF (age, 60 T 12 yr; 45% women), the interreviewer agreement for EOV was fair (J = 0.303) with 10-s discrete data averages and significantly better, but only moderate (J = 0.429) with 30-s rolling data averages. Prevalence rates of positive and indeterminate EOVs were 18% and 30% with the 10-s discrete averages and 14% and 13% with the 30-s rolling averages, respectively. VDI was strongly associated with EOV, with areas under the receiver operator characteristics curve of 0.852 to 0.890. Conclusions: Interreviewer agreement for EOV in patients with HF is fair to moderate, which can negatively affect risk stratification. VDI has strong predictive validity with EOV; as such, it might be a useful measure of prognosis in patients with HF.
KW - CARDIOPULMONARY EXERCISE TESTING
KW - GAS EXCHANGE
KW - HEART FAILURE
KW - METHODS
UR - http://www.scopus.com/inward/record.url?scp=85056432901&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056432901&partnerID=8YFLogxK
U2 - 10.1249/MSS.0000000000001423
DO - 10.1249/MSS.0000000000001423
M3 - Article
C2 - 28902683
AN - SCOPUS:85056432901
SN - 0195-9131
VL - 50
SP - 369
EP - 374
JO - Medicine and Science in Sports and Exercise
JF - Medicine and Science in Sports and Exercise
IS - 2
ER -